|  | 同义名 : | MT500 | 
| CAS号 : | 199864-87-4 | |
| 货号 : | A654799 | |
| 分子式 : | C17H16FN3 | |
| 纯度 : | 99%+ | |
| 分子量 : | 281.33 | |
| MDL号 : | MFCD20270616 | |
| 存储条件: | Pure form Inert atmosphere, 2-8°C In solvent -20°C:3-6个月-80°C:12个月 | |
| 溶解度 : | - | 
| 生物活性 | |||
|---|---|---|---|
| 靶点 | 
 | ||
| 描述 | RS-127445, a selective, high anity, orally bioavailable 5-HT2B receptor antagonist. RS-127445 potently displaced [3H]-5-HT from human recombinant 5-HT2B receptor expressed in CHO-K1 cells. The anity (pKi value) of RS-127445 for the 5-HT2B receptor was 9.5+0.1. In vitro research suggests RS-127445 potently inhibited the 5-HT evoked increase in the formation of inositol phosphates in cells expressing 5-HT2B receptor. RS-127445 potently blocked the 5-HT (10 nM) evoked increases in intracellular calcium concentrations in the HEK293 cells expressing the 5-HT2B receptor (pIC50 value of 10.4+0.1). RS-127445 potently blocked the 5-HT evoked contraction of the isolated fundus. Peak plasma concentrations were rapidly achieved with the highest concentrations being found at the first time-point measured following intravenous and intraperitonael administration (0.08 h) and by 0.25 h following dosing by the oral route of administration[3]. | ||
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
| 1 mM 5 mM 10 mM | 3.55mL 0.71mL 0.36mL | 17.77mL 3.55mL 1.78mL | 35.55mL 7.11mL 3.55mL | 
| 参考文献 | 
|---|